6.2 Photosensitizers and their mechanisms of action

Photosensitizers are key players in photodynamic therapy. They come in different types, like porphyrins and chlorins, each with unique light absorption properties. These molecules generate reactive oxygen species when exposed to light, triggering cell death in targeted tissues.

The effectiveness of photosensitizers depends on various factors. Their cellular localization, uptake, and pharmacokinetics all impact treatment outcomes. Optimizing the drug-light interval is crucial for maximizing therapeutic effects while minimizing damage to healthy tissue.

Photosensitizer Types

Porphyrin-Based Photosensitizers

Top images from around the web for Porphyrin-Based Photosensitizers

• 

  Frontiers | Photodynamic Antimicrobial Chemotherapy: Advancements in Porphyrin-Based ... View original

  Is this image relevant?

• 

  Frontiers | Photodynamic Antimicrobial Chemotherapy: Advancements in Porphyrin-Based ... View original

  Is this image relevant?

• 

  Frontiers | Emerging applications of porphyrins in photomedicine | Physics View original

  Is this image relevant?

• 

  Frontiers | Photodynamic Antimicrobial Chemotherapy: Advancements in Porphyrin-Based ... View original

  Is this image relevant?

• 

  Frontiers | Photodynamic Antimicrobial Chemotherapy: Advancements in Porphyrin-Based ... View original

  Is this image relevant?

1 of 3

Top images from around the web for Porphyrin-Based Photosensitizers

• 

  Frontiers | Photodynamic Antimicrobial Chemotherapy: Advancements in Porphyrin-Based ... View original

  Is this image relevant?

• 

  Frontiers | Photodynamic Antimicrobial Chemotherapy: Advancements in Porphyrin-Based ... View original

  Is this image relevant?

• 

  Frontiers | Emerging applications of porphyrins in photomedicine | Physics View original

  Is this image relevant?

• 

  Frontiers | Photodynamic Antimicrobial Chemotherapy: Advancements in Porphyrin-Based ... View original

  Is this image relevant?

• 

  Frontiers | Photodynamic Antimicrobial Chemotherapy: Advancements in Porphyrin-Based ... View original

  Is this image relevant?

1 of 3

• Porphyrins form the backbone of many photosensitizers used in photodynamic therapy
• Consist of four pyrrole rings connected by methine bridges
• Absorb light in the visible spectrum, typically in the red region (630-690 nm)
• Photofrin represents the first FDA-approved photosensitizer for clinical use
  • Mixture of oligomers derived from hematoporphyrin
  • Utilized in treating various cancers (esophageal, lung, bladder)
• 5-Aminolevulinic acid (ALA) serves as a prodrug in photodynamic therapy
  • Metabolized in cells to form protoporphyrin IX, an active photosensitizer
  • Applied topically or orally for treating skin conditions and certain cancers

Chlorin and Phthalocyanine Photosensitizers

• Chlorins are reduced porphyrin derivatives with enhanced absorption in the red spectrum
  • Exhibit stronger absorption at longer wavelengths compared to porphyrins
  • Examples include chlorin e6 and meso-tetra(hydroxyphenyl)chlorin
• Phthalocyanines consist of four isoindole units linked by nitrogen atoms
  • Demonstrate intense absorption in the far-red region (670-700 nm)
  • Highly stable molecules with tunable properties through metal ion coordination
  • Zinc and aluminum phthalocyanines show promise in preclinical and clinical studies

Photochemical Reactions

Type I and Type II Reactions

• Type I reaction involves electron transfer between excited photosensitizer and substrate
  • Generates reactive oxygen species like superoxide anion and hydroxyl radicals
  • Leads to oxidative damage of biomolecules (proteins, lipids, nucleic acids)
• Type II reaction results in energy transfer to molecular oxygen
  • Produces singlet oxygen, a highly reactive and cytotoxic species
  • Singlet oxygen has a short lifetime (< 40 ns) and limited diffusion distance (< 20 nm)
• Both Type I and Type II reactions can occur simultaneously during photodynamic therapy
  • Relative contribution depends on photosensitizer properties and cellular environment

Photobleaching and Oxygen Depletion

• Photobleaching refers to the light-induced degradation of photosensitizers
  • Reduces the effectiveness of photodynamic therapy over time
  • Can be used to monitor treatment progress and adjust light dosage
• Oxygen depletion occurs as a result of photochemical reactions
  • Limits the efficacy of photodynamic therapy in hypoxic tumor regions
  • Strategies to overcome oxygen depletion include fractionated light delivery and oxygen carriers

Biological Considerations

Cellular Localization and Uptake

• Photosensitizers accumulate in various cellular compartments
  • Mitochondria, lysosomes, endoplasmic reticulum, and plasma membrane
  • Localization influences the mechanism and efficiency of cell death
• Factors affecting cellular uptake include:
  • Lipophilicity of the photosensitizer
  • Charge and molecular weight
  • Presence of specific transporters or receptors on cell membranes

Pharmacokinetics and Biodistribution

• Pharmacokinetics describe the absorption, distribution, metabolism, and excretion of photosensitizers
  • Influence the timing and efficacy of photodynamic therapy
  • Vary depending on the chemical structure and administration route
• Biodistribution affects the selectivity of photodynamic therapy
  • Tumor-to-normal tissue ratio determines treatment window
  • Enhanced permeability and retention (EPR) effect contributes to tumor accumulation

Drug-Light Interval Optimization

• Drug-light interval refers to the time between photosensitizer administration and light exposure
  • Critical for achieving optimal therapeutic outcomes
  • Depends on pharmacokinetics and biodistribution of the photosensitizer
• Shorter intervals (minutes to hours) often used for vascular-targeted photodynamic therapy
  • Targets tumor vasculature to induce ischemic cell death
• Longer intervals (24-72 hours) allow for cellular accumulation and clearance from normal tissues
  • Improves selectivity and reduces side effects in surrounding healthy tissue